Can reduced co-pays boost outcomes, lower costs in diabetic patients?
Maybe not immediately, but investigators at the University of Michigan think the long-term answer may well be "yes." And what's more, there may even be a positive impact on overall medical costs. Definitive answers should be forthcoming soon as a just-lanched pilot study will be examining both of these issues over the next two years.
D003363:Cost Control; D017047:Cost Sharing / Q000706:statistics & numerical data*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D016527:Drug Costs; D006801:Humans; D008824:Michigan; D010349:Patient Compliance; D010865:Pilot Projects; D014495:Universities